August 2011 Archives

August 29, 2011

Anger Increases Risk of Cardiovascular Complications While Laughter Decreases the Risk (8.29.11)

Recent study data show that individuals suffering from cardiac disease where more likely to suffer further cardiac complications if they experienced more anger, but less likely if they laugh more frequently. When laughing the major blood vessels dilate (open up) allowing for greater blood flow.

http://www.medpagetoday.com/MeetingCoverage/ESCCongress/28243?utm_source=share&utm_medium=mobile&utm_campaign=medpage%2Biphone%20app

August 24, 2011

Celexa (citalopram hydrobromide) in High Doses Results in Abnormal Heart Rhythms

The FDA has issued a warning that Celexa (antidepressant) should be discontinued at doses exceeding 40mg daily because it increases the risk of abnormal electrical activity of the heart. These changes can be fatal. There is an increased risk with those that have a preexisting heart condition or suffer from lower than normal levels of potassium or magnesium.
To report adverse events from Celexa:

  • Complete and submit the report Online: MedWatch Online Voluntary Reporting Form (3500)
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
For additional information, go to: Celexa (citalopram hydrobromide): Drug Safety Communication - Abnormal Heart Rhythms Associated With High Doses
August 23, 2011

Human Papillomavirus (HPV) Test More Accurate in Detecting Cervical Cancer (8.23.11)

Recent data demonstrate that combining HPV testing with cytology provides higher sensitivity detection of cervical cancer than cytology alone. Recent data demonstrate that combining HPV testing with cytology provides higher sensitivity detection of cervical cancer than cytology alone.

Primary source: The Lancet Oncology
Source reference: Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

August 18, 2011

Oral Osteoporosis Drugs (bisphosphonates) May Increase Risk of Esophageal Cancer

According to the FDA recent data suggest that oral bisphosphonate drugs increase the risk of cancer of the esophagus. The FDA has not taken a firm position on this, but is simply notifying the public of the potential risk.
For further details, go to: Oral Osteoporosis Drugs (bisphosphonates): Drug Safety Communication - Potential Increased Risk of Esophageal Cancer

August 18, 2011

Terbutaline at Term Increases Fetal Heart Rate and Accelerations (8.18.11)

A recent study shows that pregnant woman given terbutaliine (labor-inhibiting drug) at term, not only experienced increased heart rate, but so did the fetus. Additionally, the fetus experienced increased accelerations in heart rate. Terbutaline: effects on the fetal heart at term

August 18, 2011

15-Minute Workouts Good For Health (8.17.11)

Studies now show that even as little as 15 minutes of exercise daily can extend life expectancy by three years.

Primary source: The Lancet
Source reference: Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study

Additional source: The Lancet
Source reference: Survival benefit associated with low-level physical activity

August 18, 2011

Predicting Higher-Risk Erb's Palsy Deliveries (8.16.11)

Although difficult to adequately assess or predict the risk of erb's palsy (brachial plexus injury) resulting from difficult deliveries (e.g., shoulder dystocia), there are a number of independent factors that can be used to determine if an expectant mother is at an increased risk of delivering a baby with erb's palsy. Those factors include, large estimated fetal weight (greater than 4500 grams), gestational diabetes, maternal obesity, and large weight gain. An approach to the prediction of neonatal Erb palsy

August 18, 2011

Hibernation Receptor in Brain May Offer Additional Time to Save Lives (8.15.11)

Scientist in Alaska have discovered a receptor in the brain of squirrels that activates hibernation. Essentially the receptor activates adenosine which is responsible for making us tired. If this receptor can be triggered in the human brain it could result in a hibernation-like state that would allow surgeons additional time to perform surgeries.

Season Primes the Brain in an Arctic Hibernator to Facilitate Entrance into Torpor Mediated by Adenosine A1 Receptors

August 18, 2011

Spicy Food May Increase Your Metabolism (8.15.11)

A small study involving overweight men demonstrates that adding spices (e.g., curry, turmeric, oregano, garlic powder, and paprika) increases metabolism. Another benefit offered by these spices is their high concentration of antioxidants.

A High Antioxidant Spice Blend Attenuates Postprandial Insulin and Triglyceride Responses and Increases Some Plasma Measures of Antioxidant Activity in Healthy, Overweight Men

August 11, 2011

Increased Blood Pressure during Second and Third Trimester Signals Increased Risk of Gestational Hypertension (8.11.11)

According to a study out of Europe, pregnant women who experience increases in systolic or diastolic blood pressure in their second and third trimesters are at an increased risk of developing gestational hypertension. Blood pressure tracking during pregnancy and the risk of gestational hypertensive disorders: The Generation R Study

August 11, 2011

New Antiviral Able to Attack All Viruses over Lifetime (8.11.11)

A remarkable new antiviral drug called DRACO (Double-stranded RNA Activated Caspase Oligomerizer) is under development and could prove to be effective in destroying all viruses over an individual's lifetime. This fascinating drug kills the replicating virus within the cells that it has attacked. Broad-Spectrum Antiviral Therapeutics

August 8, 2011

Compare Hospitals Based on Quality and Patient Satisfaction (8.8.11)

Medicare now offers a website that allows visitors to view and compare patient ratings and quality ratings of various hospitals. Go to Hospital Compare

August 3, 2011

Diflucan/Fluconazole May Increase Risk of Birth Defects (8.3.11)

According to the FDA, Diflucan (used to treat fungal infections; commonly used for yeast infections) when taken long-term and in high doses may increase the risk of birth defects when taken during pregnancy.

FDA Drug Safety Communication:Use of long-term, high-dose Diflucan (fluconazole) during pregnancy may be associated with birth defects in infants